Healthcare
Live Price
Offline$8.53
+6.89% today
1Y Change
+23.62%
Window
Jun 27, 2025 โ Jun 22, 2026
Coverage: 246 bars ยท Jun 27, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Emergent BioSolutions Inc. (EBS) is a Healthcare stock with a market cap of $470.00M and listed on NYSE. The stock last traded around $8.53 and up 23.6% across the available one-year price window (Jun 27, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of -28.8%, EPS growth of +127.2%, a dividend yield of 0.0%. What stands out right now is revenue -28.8%, EPS +127.2%, free cash flow +338.0% with operating margin 10.5% and ROIC -14.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines EBS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EBS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EBS Max Drawdown
-44.24%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for EBS and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.